Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer.
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer. N Engl J Med. 2025 Jun 19; 392(23):2346-2356.
View in:
PubMed
subject areas
Administration, Oral
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Carcinoma, Renal Cell
Erlotinib Hydrochloride
Female
Humans
Infusions, Intravenous
Kaplan-Meier Estimate
Kidney Neoplasms
Leiomyomatosis
Male
Middle Aged
Neoplastic Syndromes, Hereditary
Response Evaluation Criteria in Solid Tumors
Skin Neoplasms
Treatment Outcome
Uterine Neoplasms
authors with profiles
Abhinav Sidana